United States Diabetes Devices Market Report by Types, End User, Distribution Channel, State and Companies Analysis 2026-2034

United States Diabetes Device Markets Size & Forecast 2026-2034

The diabetes devices market in the United States is estimated to grow from US$ 9.96 billion in 2025 to US$ 18.92 billion by 2034, registering a compound annual growth rate (CAGR) of 7.40% from 2026 to 2034. Factors such as the rising incidence of diabetes, increased usage of continuous glucose monitoring systems, rising usage of insulin delivery devices, and technological developments to improve convenience for patients drive the growth of the diabetes devices market.

United States Diabetes Device Market Outlook

Diabetes care devices are biomedical instruments designed for glucose level measurement in the bloodstream. Moreover, these devices are also employed for the administration of insulin or other treatments for effectively managing diabetes among several individuals. Some of the common diabetes care devices comprise glucose meters, continuous glucose monitoring systems, insulin pens, insulin pumps, 'smart' insulin infusion systems, as well as mobile applications. Moreover, diabetes care devices also have essential roles in ensuring optimal glucose levels in an individual with both type 1 and type 2 diabetes. Further, these devices are becoming more advanced with the aid of 'digital' technology.

In the USA, diabetes-related devices are widely accepted due to the high incidence of diabetes and awareness about managing the diseases. Patients as well as healthcare professionals are showing interest in more sophisticated devices that are accurate, user-friendly, and provide continuous monitoring. In the US, the healthcare infrastructure enables easy accessibility of these technologies, and insurance coverage has facilitated the use of CGM systems as well as insulin pumps. With the rise in the importance of preventive healthcare, patient monitoring from a distance, and customized treatment, the demand for connected diabetes devices of all ages has been accelerated.

Growth Driver in the US Diabetes Device Market

Increased Cases of Diabetes & Elderly Population

The growing incidence of diabetes in the United States is a major driving force in the diabetes devices market. The incidence of both type 1 and 2 diabetes is projected to increase due to lifestyle factors such as a sedentary lifestyle, obese populations, and unhealthy food habits. Furthermore, an aging population acts as a major multiplier for diabetes, as older people are more vulnerable to diabetes and its co-existing conditions. As a result, the growing population with diabetes fuels the demand for CGM, insulin pumps, as well as self-care products for diabetes. Diabetes management devices help diabetic patients control their condition effectively, minimize hospital visits, and also prevent long-term co-existing conditions. Moreover, the growing incidence of diabetes ensures a steady demand for diabetes management devices in the market because, by 2050, the number of people living with diabetes is projected to increase by more than twofold in the United States, as nearly a third of over 65 U.S. populations are currently affected by diabetes." "Currently, diabetes is a leading contributor to morbidity, but mortality is primarily due to macrovascular events in these populations."

Technological Advances and Digital Integration

The U.S. diabetes devices market is being propelled by the current state of rapid technological advances. Continuous glucose monitoring systems, "smart" insulin pens, and closed-loop insulin delivery systems have led to a paradigm shift in the treatment of diabetes. The integration with smartphone applications, cloud-based platforms, and wearables enables patients to monitor their data in real time. Furthermore, healthcare professionals have become reliant on data from diabetes devices for remote monitoring and therapy adjustment. Along with the increasing adoption of digital health, there is increasing acceptance of advanced diabetes devices in the market. December 2024: Dexcom announced the release of the Generative AI platform using the Google Cloud Vertex AI and Gemini models. It assesses the unique patterns of the patient's glucose, activities, and sleep to provide patients with personalized recommendations that promote real-time lifestyle changes.

Rise Awareness/Preventive Health Care

Rising awareness about diabetes management and prevention has fueled the adoption of diabetes devices in the US market. There has been increased awareness among patients about the significance of frequent glucose checks and taking preventive measures for controlling diabetes. The main focus of preventive healthcare projects revolves around adopting healthy strategies for managing prevailing diseases and cutting down rising healthcare costs. The use of diabetes devices helps in self-management and empowers patients to control their condition effectively. Companies and healthcare programs encourage patients to adopt device-assisted monitoring for positive results. The increasing focus on preventive and patient-centric care has remarkably increased market demand for diabetes management devices for continuous glucose monitoring and insulin delivery systems. The success of the US National Diabetes Prevention program in reaching almost half a million participants in the last ten years has simply represented a tiny fraction of the total number of citizens at risk of around 88 million in the US and UK that have shown promising outcomes in real-world settings but also illustrated difficulties in reaching communities and retaining program participation.

Challenge in the United States Diabetes Device Market

In the United States diabetes device market

Higher expenses associated with the use of advanced diabetes technology are still one of the challenges in the U.S. market. Continuous glucose monitoring systems, insulin pumps, and intelligent systems are associated with substantial capital and recurring expenditures. Though there are reimbursements, the reimbursement structures are extremely varied depending upon the organization and the patients as well. Out-of-pocket expenditures might prevent the use of devices, especially in the absence of insurance plans. Higher cost consideration might hinder the adoption and prevent the discontinuation of the use of devices.

Device Complexity and User Adoption Barriers

Though a lot of advancements are being made in the field of technology, complexity may be a hindrance to the widespread adoption of devices. Many patients experience difficulties when working with advanced devices. Older patients and less technologically savvy patients may experience troubles with the calibrations of the devices and the interpretation of the results. If the devices malfunction or connectivity is a problem, the confidence of the patients may be affected. However, training and service costs increase the burden on healthcare costs.

United States SMBG Device Market

The self-monitoring of blood glucose (SMBG) market in the United States is an established and quite popular application in diabetes management. SMBG systems, also referred to as glucometers and glucose strips, remain popular among patients who have either type 1 and type 2 diabetes as these systems enable patients to measure their glucose levels in their own residences. The SMBG systems continue to remain a vital component in the lives of patients requiring insulin and those taking oral medicines for diabetes management. Affordability, simplicity in use, and universal access have remained an impetus for the SMBG systems in the United States. Even though growth in this application has slowed down relative to other revolutionary technologies in diabetes management, demand for replacements and use by cost-conscious consumers has ensured that it remains stable in terms of market dynamics in the United States.

United States CGM Device Market

The market for continuous glucose monitoring systems (CGM devices) is one of the rapidly increasing sectors in the overall diabetes devices market in the United States. In fact, the CGM devices market is poised to make diabetes management easier because the devices offer real-time values, trend information, and alerts. They also greatly reduce the need for frequent finger stick testing. The use of CGM devices is popular among people suffering from type 1 diabetes, and there is also increasing adoption among insulin-dependent people with type 2 diabetes. Smartphone integration, insulin pump integration, and popular digital health platforms have further increased ease of use and adoption.

United States Insulin Pumps Market

In the United States, the insulin pumps devices market is driven because of the need for accurate and automated insulin infusion. Insulin pumps offer continuous subcutaneous insulin infusion and are also more portable and flexible as opposed to multiple daily injections of insulin. Insulin pumps are mainly used because of the high demand among type 1 diabetic patients and also those needing intensive insulin treatment. Technological advancements have led to the development of "smart pumps" as well as automated insulin infusion systems, making them more user-friendly and safer to use. Along with the use of CGM systems, the development of closed-loop systems has also improved their efficacy.

US Insulin Pen Devices Market

Insulin pens are popular in the United States because of convenience, portability, and accuracy of dosage. The benefits of using insulin pens include ease of administration of the insulin compared with traditional syringes. Insulin pens are preferred by type 1 and type 2 diabetic individuals, most of whom are initially prescribed with insulin. There are disposable and reusable pens for diabetes management according to patient preference. Advances in the development of insulin pens include smart pens which monitor the dose taken by recording it while enabling the user to operate a mobile device. The market for insulin pens has been steadily increasing because of ease of administration and popularity among diabetes patients.

United States Diabetes Device Diagnostics Centers Market

The diagnostic centers also play a significant part in the US diabetes market with regard to assisting in the diagnosis and monitoring of diabetes in order to optimize therapies. The SMBG devices, CGMs, and professional glucose monitor devices in these diagnostic centers help in understanding glucose activity and treatment response in these patients. The diagnostic centers also play a significant part in treating diabetes initially and in managing this disease. With regard to preventive aspects of healthcare and early interventions becoming a goal in healthcare now, this market also gains support from these needs.

United States Diabetes Device Retail Pharmacies Market

Retail pharmacies are one of the prominent distribution channels for diabetes devices in the United States. Retail pharmacies make it easy for patients to get SMBG devices, insulin pens, CGM sensors, and more. Retail pharmacies are an optimal distribution channel for diabetes devices because of their widespread availability and the assistance of pharmacists. Retail pharmacies can also facilitate patient education, prescription collection, and insurance services. Wider distribution of advanced diabetes devices in retail pharmacies improves the convenience of accessibility. Retail pharmacies continue to remain an essential part of diabetes distribution in the rising cases of diabetes.

California Diabetes Device Market

California is a reflection of one of the biggest and most advanced markets for diabetes devices in the US. Based on a large population, high prevalence of diabetes, and focus on preventive healthcare, there is continuous demand for glucose monitoring devices as well as insulin delivery devices in the state. Being a leading focus for healthcare innovation, it is easily adopting continuous glucose monitoring systems, smart insulin pens, and insulin pumps. There is a high degree of preference for solutions that help in monitoring on a real-time basis. Easy access to specialty medical clinics, endocrinologists, and retail pharmacies is another reason for high adoption. In addition to these factors, the focus on wellness, early diagnosis, and management of chronic conditions is adding to the growth. Being a hub for healthcare innovation, it is a leader among markets for advanced diabetes devices.

Texas Diabetes Device Market

The Texas diabetic devices market is propelled by the substantial and rising pool of diabetic patients, with the rising healthcare infrastructure in the rural and metropolitan areas. The widespread type 2 diabetic cases, driven by lifestyle and demographic factors, have led to significant demand for SMBG devices, insulin pens, and CGM systems. In Texas, a combination of advanced healthcare facilities is prevalent within the metropolitan areas and a rising interest in healthcare is witnessed within the rural areas. Cost-efficient solutions are always significant, but awareness of advanced technologies is also rising. Retail pharmacies and diagnostic facilities are of significant use to the distributors and consumers. With a focus on improved access to healthcare and the rising requirement to handle chronic conditions, the Texas diabetic devices market is a substantial volume and a rising growth area.

New York Diabetes Devices Market

Favorable healthcare infrastructure, awareness levels, and a strong focus on prevention, the diabetes devices market in the state of New York thrives. City dwellers are primary demand-driven customers for more sophisticated glucose monitoring solutions, especially those with mobile health platforms. There is considerable use of diabetes devices in hospitals, speciality healthcare settings, and diagnostic labs for monitoring and managing diabetes. With a largely diverse population in the state demanding devices of all types, from SMBG devices to insulin pumps, insulin pens included, the market in New York remains stable with a strong innovation-driven theme for diabetes devices.

Washington Diabetes Devices Market

The diabetic care device market in Washington is driven by effective preventive healthcare practices and an increasing interest in digital healthcare technologies. There is an increasing interest in devices facilitating continuous monitoring, connectivity, and personalized healthcare. Wearable CGM devices and intelligent insulin pumps are increasingly popular, especially among younger populations more familiar with technology. The healthcare system in Washington focuses on early detection and chronic management of conditions, facilitating continued use of diabetic care devices. Retail pharmacies and clinics also have an important role to play in device accessibility and patient support. Health awareness, technology, and patient-centric medical care as emphasized by Washington contribute to continued growth in all segments of the diabetic device market.

Market Segmentations

Types

Self-Monitoring Devices

• Test Strips
• Lancets
• Blood Glucose Meters

Continuous Glucose-Monitoring Devices

• Sensors
• Transmitter
• Receiver

Insulin Pumps

• Patch Pumps
• Tethered Pumps
• Consumables

Insulin Pens

• Disposable Insulin Pen
• Reusable Insulin Pen

End User

• Hospitals
• Diagnostics Centers
• Homecare

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies

Top States

• California
• Texas
• New York
• Florida
• Illinois
• Pennsylvania
• Ohio
• Georgia
• New Jersey
• Washington
• North Carolina
• Massachusetts
• Virginia
• Michigan
• Maryland
• Colorado
• Tennessee
• Indiana
• Arizona
• Minnesota
• Wisconsin
• Missouri
• Connecticut
• South Carolina
• Oregon
• Louisiana
• Alabama
• Kentucky
• Rest of United States

All companies have been covered with 5 Viewpoints

• Overviews
• Key Person
• Recent Developments
• SWOT Analysis
• Revenue Analysis

Company Analysis:

• BD
• Roche
• Medtronic
• Insulet Corporation
• Abbott Laboratories
• Dexcom Inc.
• Tandem Diabetes Care
• Ypsomed AG
• Novo Nordisk A/S
• Eli Lilly